scholarly journals Effects of alternate day calorie restriction and exercise on cardio-metabolic risk factors in overweight and obese adults: an exploratory randomized controlled study

2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Minsuk Oh ◽  
Sue Kim ◽  
Ki-Yong An ◽  
Jihee Min ◽  
Hyuk In Yang ◽  
...  
2019 ◽  
Author(s):  
Juan Zhou ◽  
Dan Zhao ◽  
Ning Wang ◽  
Zhiwei Zeng ◽  
Changyi Wang ◽  
...  

Abstract Background: The prevalence of central obesity is increasing consistently, and visceral fat is associated with increased production of inflammatory factors and metabolic risk factors. Lutein might retard the development of metabolic disease through its antioxidant and anti-inflammatory properties. Furthermore, epidemiological studies have associated higher dietary intake and serum levels of lutein with decreased adiposity. However, few randomized controlled trials (RCTs) have shown the effects of lutein supplementation on inflammatory biomarkers and metabolic risk factors, especially in adults with central obesity. Methods: This study will be conducted as a double-blinded, parallel placebo-controlled clinical trial in which 120 people with central obesity aged 18-60 years old and willing to provide informed consent will be randomly assigned to the intervention or placebo group in a 1:1 ratio according to sex, age and waist circumference. The intervention group will receive 10 mg daily lutein supplementation for 12 weeks to explore the effect of lutein supplementation on serum lutein, glycaemic and lipid profiles, inflammatory factors and body composition. Two populations (intention-to-treat population and per-protocol population) will be used in the data analyses. Discussion: Our findings from this trial will contribute to the knowledge of the association between lutein supplementation and inflammatory biomarkers and metabolic risk factors in people with central obesity, which will offer a possibility for the prevention of inflammatory diseases.


2019 ◽  
Author(s):  
Juan Zhou ◽  
Dan Zhao ◽  
Ning Wang ◽  
Zhiwei Zeng ◽  
Changyi Wang ◽  
...  

Abstract Introduction: The prevalence of central obesity is sustained growth and visceral fat is associated with increased production of inflammatory factors and metabolic risk factors. Lutein might retard the development of the metabolic disease through the antioxidant and anti-inflammatory properties. Furthermore, epidemiological studies associate higher dietary intakes and serum levels of lutein with decreased adiposity. However, few of the randomized controlled trails (RCT) have showed the effects of lutein supplementation on inflammatory biomarkers and metabolic risk factors, especially in adults with central obesity. Methods and analysis: This study will be conducted as a double-blinded, and parallel placebo-controlled clinical trial in which 120 central obesity people aged 18-60 years old and willing to provide informed consent will be randomly assigned to intervention and placebo group in a 1:1 ratio according to gender, age and waist circumstance. The intervention group will receive daily lutein 10 mg supplementation for 12 weeks to explore the effect of lutein supplementation on serum lutein, glycemic and lipid profiles, inflammatory factors and body composition. Two population (intention-to-treat population and per-protocol population) will be used in the data analyses. Discussion: Our findings from this trial will contribute to the knowledge of the association between lutein supplementation and inflammatory biomarkers, metabolic risk factors in people with central obesity, which will offer us a possibility for the prevention of inflammatory diseases. Trail registration: Chinese Clinical Trial Registry, ChiCTR1800018098. Registered on 30 August 2018. Keywords: Lutein supplementation, central obesity, inflammatory biomarkers, metabolic risk factors.


2019 ◽  
Author(s):  
Juan Zhou ◽  
Dan Zhao ◽  
Ning Wang ◽  
Zhiwei Zeng ◽  
Changyi Wang ◽  
...  

Abstract Background: The prevalence of central obesity is increasing consistently, and visceral fat is associated with increased production of inflammatory factors and metabolic risk factors. Lutein might retard the development of metabolic disease through its antioxidant and anti-inflammatory properties. Furthermore, epidemiological studies have associated higher dietary intake and serum levels of lutein with decreased adiposity. However, few randomized controlled trials (RCTs) have shown the effects of lutein supplementation on inflammatory biomarkers and metabolic risk factors, especially in adults with central obesity. Methods: This study will be conducted as a double-blinded, parallel placebo-controlled clinical trial in which 120 people with central obesity aged 18-60 years old and willing to provide informed consent will be randomly assigned to the intervention or placebo group in a 1:1 ratio according to sex, age and waist circumference. The intervention group will receive 10 mg daily lutein supplementation for 12 weeks to explore the effect of lutein supplementation on serum lutein, glycaemic and lipid profiles, inflammatory factors and body composition. Two populations (intention-to-treat population and per-protocol population) will be used in the data analyses. Discussion: Our findings from this trial will contribute to the knowledge of the association between lutein supplementation and inflammatory biomarkers and metabolic risk factors in people with central obesity, which will offer a possibility for the prevention of inflammatory diseases.


Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 754-P
Author(s):  
JOANNA MITRI ◽  
SHAHEEN TOMAH ◽  
ADHAM MOTTALIB ◽  
VERONICA SALSBERG ◽  
SAHAR ASHRAFZADEH ◽  
...  

2020 ◽  
Vol 79 (OCE2) ◽  
Author(s):  
Monica Dinu ◽  
Giuditta Pagliai ◽  
Donato Angelino ◽  
Alice Rosi ◽  
Margherita Dall'Asta ◽  
...  

AbstractIntroduction:The prevalence of overweight, obesity, and their related complications is increasing worldwide. We aimed to summarise and critically evaluate the effects of different popular diets on anthropometric parameters and metabolic risk factors.Material and methods:An umbrella review of meta-analyses of randomized controlled trials was conducted according to the Joanna Briggs Institute Umbrella Review Methodology. The review protocol has been registered on PROSPERO (ID: CRD42019126103). Medline, Embase, Scopus, Cochrane Database of Systematic Reviews, and Web of Science were searched from inception to April 2019 to identify meta-analyses of randomized controlled trials that examined the effects of different diets on anthropometric parameters and metabolic risk factors. For each association, we estimated the summary effect size by random-effects and fixed-effects models, the 95% confidence interval, and the 95% prediction interval. We also assessed the between-study heterogeneity and evidence for small-study effects. We further applied standardized methodological criteria to evaluate the epidemiological credibility of the statistically significant associations.Results:Overall, 80 articles reporting 495 unique meta-analyses were examined, covering a wide range of popular diets: low-carbohydrate (n = 21 articles), high-protein (n = 8), low-fat (n = 9), palaeolithic (n = 2), low glycaemic index/load (n = 12), intermittent energy restriction (n = 6), Mediterranean (n = 11), Nordic (n = 2), vegetarian (n = 9), Dietary Approaches to Stop Hypertension or DASH (n = 6), and portfolio dietary pattern (n = 1). The methodological quality of most articles (n = 65; 81%), evaluated using the AMSTAR-2 questionnaire, was low or critically low. The strength of evidence was generally weak. The most consistent evidence was reported for Mediterranean diet, with suggestive evidence of an improvement in weight, body mass index (BMI), total cholesterol, glucose and blood pressure. Suggestive evidence of an improvement in weight and blood pressure was also reported for DASH diet. Low-carbohydrate, high-protein, low-fat and low-glycaemic index/load diets showed suggestive and/or weak evidence of a reduction in weight and BMI, but contrasting evidence for lipid, glycaemic and blood pressure parameters, suggesting potential risks of unfavourable effects. Finally, evidence for palaeolithic, intermittent energy restriction, Nordic, vegetarian and portfolio dietary patterns was graded as weak or not statistically significant.Discussion:Most meta-analyses showed low methodological quality and the strength of evidence, assessed using evidence classification criteria, was generally weak. Among all the diets evaluated, Mediterranean diet had the strongest and most consistent evidence of a positive effect on both anthropometric parameters and metabolic risk factors.


Sign in / Sign up

Export Citation Format

Share Document